Calice-Silva Viviane, Nerbass Fabiana Baggio
Nephrology Division, Pro-rim Foundation, Joinville, Brazil.
Medicine School, Universidade da Região de Joinville (Univille), Joinville, Brazil.
Front Nephrol. 2022 Jul 25;2:932562. doi: 10.3389/fneph.2022.932562. eCollection 2022.
Incremental peritoneal dialysis (PD) is characterized as less than a "standard dose" PD prescription. Compared to standard treatment, it has many potential advantages, including better preservation of residual renal function, a lower risk of peritonitis, and a decreased care delivery burden while reducing the environmental impact and economic cost. Unplanned PD can be defined when treatment starts up to 14 days after catheter insertion and is recognized as a safe and feasible clinical approach. In this perspective paper, we briefly discuss both strategies and share our experience and clinical routine in managing incremental PD after unplanned initiation.
递增性腹膜透析（PD）的特点是腹膜透析处方低于“标准剂量”。与标准治疗相比，它有许多潜在优势，包括更好地保留残余肾功能、降低腹膜炎风险、减轻护理负担，同时减少对环境的影响和经济成本。非计划性腹膜透析可定义为在导管插入后14天内开始治疗，被认为是一种安全可行的临床方法。在这篇观点论文中，我们简要讨论这两种策略，并分享我们在非计划性起始后管理递增性腹膜透析的经验和临床常规。
